Literature DB >> 8843218

Control of fecal peritoneal infection in mice by colony-stimulating factors.

J Barsig1, D S Bundschuh, T Hartung, A Bauhofer, A Sauer, A Wendel.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) recruits and primes neutrophilic granulocytes. The role of endogenous and exogenous G-CSF was examined in a murine fecal peritoneal infection model characterized by rapid production of high levels of circulating G-CSF. Pretreatment with anti-murine G-CSF for 5 days reduced neutrophil counts by 50% and sensitized mice to sublethal peritonitis. There were more aerobic bacteria in livers of antiserum-pretreated animals but fewer neutrophils in peritoneal cavities. Pretreatment with 100 micrograms/kg recombinant murine G-CSF intravenously for 2 days raised neutrophil counts 5-fold and significantly protected animals against lethal peritonitis. A similar prophylactic administration of murine granulocyte-macrophage (GM)-CSF neither augmented leukocyte numbers nor protected infected mice. These results show a dissociation between the pharmacologic properties of GM-CSF and G-CSF and demonstrate the crucial role of endogenous G-CSF in controlling neutrophil-dependent defense against bacterial invasion in infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843218     DOI: 10.1093/infdis/174.4.790

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.

Authors:  Sevim Aydin; Rahmet Caylan; Kemalettin Aydin; Esin Yulug; Engin Yenilmez; Iftihar Koksal
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes.

Authors:  Christine Keller; Reinhard Hoffmann; Roland Lang; Sven Brandau; Corinna Hermann; Stefan Ehlers
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  Temporal sequence of pulmonary and systemic inflammatory responses to graded polymicrobial peritonitis in mice.

Authors:  C Stamme; D S Bundschuh; T Hartung; U Gebert; L Wollin; R Nüsing; A Wendel; S Uhlig
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Angiotensin II increases host resistance to peritonitis.

Authors:  K Rodgers; S Xiong; T Espinoza; N Roda; S Maldonado; G S diZerega
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

6.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

7.  Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.

Authors:  Artur Bauhofer; Alexander Torossian; Wilfried Lorenz; Martin Middeke; Ulrike Plaul; Philipp Schütz; Benno Stinner; Markus Hattel; Ilhan Celik
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

8.  Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.

Authors:  Alieke G Vonk; Mihai G Netea; Johan H van Krieken; Paul E Verweij; Jos W M van der Meer; Bart Jan Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.

Authors:  W N Hustinx; C P Van Kessel; E Heezius; S Burgers; J W Lammers; I M Hoepelman
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

10.  Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression.

Authors:  Isabel Diterich; Carolin Rauter; Carsten J Kirschning; Thomas Hartung
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.